Voloridge Investment Management
DNLI icon

Voloridge Investment Management’s Denali Therapeutics DNLI Stock Holding History

Voloridge Investment Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-591,461
Closed -$9.77M – 1074
2025
Q4 		$9.77M Sell
591,461
-344,769
-37% -$5.82M 0.03% 586
2025
Q3 		$13.6M Buy
936,230
+165,703
+22% +$2.38M 0.05% 455
2025
Q2 		$10.8M Buy
770,527
+468,554
+155% +$6.59M 0.04% 524
2025
Q1 		$4.11M Buy
+301,973
New +$5.79M 0.02% 836
2024
Q3 		– Sell
-54,056
Closed -$1.26M – 1210
2024
Q2 		$1.26M Sell
54,056
-73,214
-58% -$1.41M ﹤0.01% 1021
2024
Q1 		$2.61M Buy
+127,270
New +$2.39M 0.01% 800
2023
Q3 		– Sell
-36,444
Closed -$1.08M – 1435
2023
Q2 		$1.08M Buy
36,444
+26,739
+276% +$752K 0.01% 1108
2023
Q1 		$224K Sell
9,705
-11,782
-55% -$324K ﹤0.01% 1301
2022
Q4 		$598K Sell
21,487
-20,869
-49% -$621K ﹤0.01% 1244
2022
Q3 		$1.3M Sell
42,356
-5,702
-12% -$185K 0.01% 1094
2022
Q2 		$1.41M Buy
48,058
+10,669
+29% +$279K 0.01% 1109
2022
Q1 		$1.2M Buy
37,389
+23,448
+168% +$807K 0.01% 1086
2021
Q4 		$622K Sell
13,941
-4,075
-23% -$193K ﹤0.01% 1374
2021
Q3 		$909K Buy
+18,016
New +$1.02M 0.01% 1311
2021
Q2 		– Sell
-27,958
Closed -$1.6M – 1636
2021
Q1 		$1.6M Buy
27,958
+13,884
+99% +$929K 0.01% 886
2020
Q4 		$1.18M Sell
14,074
-105,805
-88% -$6.4M 0.01% 915
2020
Q3 		$4.29M Buy
119,879
+109,476
+1,052% +$3.3M 0.04% 484
2020
Q2 		$252K Buy
+10,403
New +$245K ﹤0.01% 1162

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Voloridge Investment Management's DNLI Position: Q1 2026 in Review

Voloridge Investment Management sold out of Denali Therapeutics (DNLI) in Q1 2026, closing a stake of 591,461 shares — an estimated $9.77M sold.

Voloridge Investment Management first reported a position in DNLI in Q2 2020 and held it in 18 quarters. The position peaked at $13.6M in Q3 2025. 269 funds tracked by Wall St. Rank hold DNLI as of Q1 2026.

  • Voloridge Investment Management reported no remaining Denali Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 591,461 Denali Therapeutics shares in Q1 2026, an estimated $9.77M.
  • Voloridge Investment Management first reported a position in Denali Therapeutics in Q2 2020 and held it in 18 quarters.
  • Voloridge Investment Management's Denali Therapeutics position peaked at $13.6M in Q3 2025.
  • 269 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.